Clinical Trial Update: Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for secukinumab in psoriasis, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2018-12-28